Vicore Pharma Holding AB

VCRE | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.80

-$0.40 (-3.92%)

At close: Oct 30, 2026, 4:00 PM ET

$9.61

-$0.19 (-1.94%)

After-hours: Oct 30, 2026, 4:34 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.92%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

+1.0 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #923/1028 (Top 90%)

Full Analysis

Key Statistics

Market Data

Market Cap $276.83M

1D Range

9.74 10.21

52W Range

8.66 16.25

Valuation (TTM)

PE -9.74

PB 30.47

EV/EBITDA -10.41

Valuation (NTM)

Forward PE N/A

Forward PEG -1.54

Price Target $25.00

Cash Flow

FCF Yield -8.3%

SBC Adj. FCF Yield -8.3%

SBC Impact -0.1%

Margins

Gross Margin 81.0%

Operating Margin -21455.4%

FCF Margin -16982.6%

Growth (CAGR)

Revenue 3Y | 5Y -89.1% | N/A

Dil EPS 3Y | 5Y -71.5% | N/A

FCF 3Y | 5Y -45.3% | N/A

Returns

ROA -54.0%

ROE -53.7%

ROIC -61.3%

Financial Health

Net Cash

kr93.41M ($9.64M)

Current Ratio 12.68

Interest Coverage -52.06

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include ...

Sector Healthcare

Industry Biotechnology

Employees 37

IPO Date Jul 2, 2026

Website www.vicorepharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.